Close Menu

NEW YORK – Solid earnings reports amid the increasing demand for COVID-19 testing led to a hearty uptick in the share prices of many diagnostics companies in July as the 360 Index grew 13 percent month over month.

The uptick followed a modest 2 percent rise in the index in June.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.